Literature DB >> 2601704

Serum-inducible expression of transfected human c-myc genes.

A Richman1, A Hayday.   

Abstract

Activation of the c-myc proto-oncogene is implicated in the initiation or progression of many vertebrate cancers. In nontransformed cells, the expression of c-myc is induced by growth factors. Studies have indicated that such induction is effected by multiple mechanisms. To study regulation of c-myc expression, a transfection system has been developed in which introduced c-myc genes exhibit serum-responsive activity. The responsiveness assayed is not mediated by increased transcription initiation. Rather, it is effected at a point(s) between transcription and stabilization of the RNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2601704      PMCID: PMC363647          DOI: 10.1128/mcb.9.11.4962-4969.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  Drosophila sex determination: a cascade of regulated splicing.

Authors:  J Hodgkin
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

Review 4.  Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.

Authors:  S Cory
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

5.  A FOS protein is present in a complex that binds a negative regulator of MYC.

Authors:  N Hay; M Takimoto; J M Bishop
Journal:  Genes Dev       Date:  1989-03       Impact factor: 11.361

6.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

7.  Posttranscriptional regulation of cellular gene expression by the c-myc oncogene.

Authors:  G C Prendergast; M D Cole
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

8.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

9.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

10.  daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex.

Authors:  M Caudy; H Vässin; M Brand; R Tuma; L Y Jan; Y N Jan
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

View more
  4 in total

1.  c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H-2K/c-myc transgenic mice.

Authors:  D Morello; M J Fitzgerald; C Babinet; N Fausto
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.

Authors:  E DesJardins; N Hay
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

3.  Gamma delta T-cell lines isolated from intestinal epithelium respond to a B-cell lymphoma.

Authors:  Y Sano; E Dudley; S Carding; R H Lin; A C Hayday; C A Janeway
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

4.  Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.

Authors:  A Polack; R Feederle; G Klobeck; K Hörtnagel
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.